I'm in Seoul locked TF in in my hotel room, running our team for newest @BioProtocol launches: both achieved 20x performance + science fully funded + close to $2m in volume. I'm here for infamous Korea Blockchain Week after 24h of travel bc 2 of my flights were cancelled due to hacker attacks in Europe, then 2h of traffic jams direct to present at @DesciSeoul - then a VIP dinner by our friends at @Presto_Labs met their CEO, @MagicEden founder + - the Korean $BIO community is really strong + there's some great local science + manufacturing we're keen on. I'm also here to unveil @dermadao who is starting directly with a real skincare product. Today, caught up sleep for 12h to get a 75% whoop recovery. Gotta say KBW is pretty awesome, we're co-hosting an event today, had so many meeting requests but instead decided to lock in on launches. Current market sideways and correction is good, because its made launches less frothy enabling larger investors to enter at lower valuations. Results speak for themselves: Important PSA: dexscreener is not accurate, we're fixing DeFi routing. Easiest way is to buy via @Uniswap on @base . Below is a recap based on my own calculations at time of writing (NFA): Performance: $BIOMEAI $1m volume in the first hour, ignition sale price was 0.21 BIO, currently trading at 4.6 BIO - that's a 21x. Team is fully funded, with token supply 10m the FDV sits at $6.6m: Our second agent launch with @BiomeAI - microbiome agent is consumer facing gathering user data for precision diet & lifestyle recommendations, then later product sales (novel probiotics for instance). @kiho6redape @katbu00 @w1kke are true builders, DeSci web3/OGs, their community is buzzing + great scientists on board. Performance: $EDMT $350k volume since launch, ignition price was 0.625 BIO, now trading at 14.3 so approx 23x, with 2m supply price is 4.4m at $2.2: @BioProtocol first IPT launch with @psy_dao @edmtcomms this one hits close to home as I'm a big fan of the utility of the substance and researcher behind it (who chooses to still be anon) + University of Florida. This is real, novel IP from one of the worlds top top psychedelic scientists. Research is fully funded + the IPT model includes a novel buyback mechanism with programmatic univ3 positions leading to buybacks of $PSY and $eDMT. One reason for why the pricing may be similar despite the difference in volume and interest is the circulating supply in the ignition: biomeAI chose 40%. PsyDAO chose 20%. I personally think this makes a lot of sense, agents need to attract a large crowd of people globally and its simply a software system initially + token. IPTs are more specialised, already compose a RWA - the seller can decide how much to sell, they attract a smaller crowd of more specialised buy/hold investor. They're also more attractive for industry though. But historically trading volume on IPTs is low, and agents will be much more accessible to consumers long-term in my view. If you already feel lost, within the coming days we'll have @Aubrai_ launch the first AI generated IPT 🤪 - I'll share more about @Molecule_dao IPT as an asset class ASAP. We're also trying as hard as possible to fix bugs + refine the XP system. It will get a lot better! Thank you to our entire team @BioProtocol + co-founder @cl2pp who are working +80h weeks myself included, a big kudos to our yapper community for staying patient with XP, and all our $BIO stackers and stakers The liquid science will flow - if we can grow the bio economy sufficiently, nothing stops us from launching with the likes of @Jiankui_He or @eboyden3 both who we're in active contact with - the key is liquidity bio/acc